收回:沃贡因在临床前研究中观察到的治疗潜力
Evidence-based complementary and alternative medicine : eCAM
|December 21, 2023
概括
这篇文章已被撤回. 原始研究不再被认为是有效的科学文献.
科学领域:
- 科学出版标准的科学出版标准.
- 撤回通知 撤回通知
背景情况:
- 确保科学文献的完整性至关重要.
- 撤回的目的是纠正或从科学记录中删除有缺陷的研究.
研究的目的:
- 为了正式撤回DOI标识的物品: 10.1155/2021/9935451.
- 通知科学界这一撤回.
主要方法:
- 随后进行了正式的撤回程序.
- 撤回通知发布以提醒读者.
主要成果:
- 文章DOI: 10.1155/2021/9935451已经正式撤回.
- 此操作将该文章从当前的科学话语中删除.
结论:
- 撤回的文章不应引用或依赖.
- 保持科学出版物的准确性是一个关键的责任.
相关概念视频
Preclinical Development: Overview
4.4K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.4K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K


